Supawat Ratanapo
Georgia Regents University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Supawat Ratanapo.
Nephrology | 2015
Wisit Cheungpasitporn; Charat Thongprayoon; Wonngarm Kittanamongkolchai; Narat Srivali; Peter J. Edmonds; Supawat Ratanapo; Ittikorn Spanuchart; Stephen B. Erickson
The objective of this meta‐analysis was to compare the effects of off‐pump and on‐pump coronary artery bypass grafting (CABG) on acute kidney injury (AKI) and the need of dialysis after surgery.
Cardiovascular Revascularization Medicine | 2018
Hoyle Whiteside; Supawat Ratanapo; Arun Nagabandi; Deepak Kapoor
INTRODUCTION Elective insertion of a percutaneous circulatory assist device (PCAD) in high-risk patients is considered a reasonable adjunct to percutaneous coronary intervention (PCI). There is limited data examining the safety and efficacy of rotational atherectomy (RA) without hemodynamic support in patients with reduced left ventricular ejection fraction (LVEF). METHODS We retrospectively identified 131 consecutive patients undergoing RA without elective PCAD over a three-year period. Patients were categorized into three groups: LVEF ≤30%, LVEF 31-50%, and LVEF >50%. The incidence of procedural hypotension, major adverse cardiac events (MACE), and mortality were recorded. RESULTS Statistical analysis included 18, 42, and 71 patients with LVEF ≤30%, 31-50%, and >50%, respectively. Bailout hemodynamic support was required in four cases. Analysis revealed a significant trend as bailout hemodynamic support was required in 11.1% vs 2.4% (P = 0.1551) in the ≤30% vs 31-50% and 11.1% vs 1.4% (P = 0.0416) in the ≤30% vs >50% subgroups. Combined subgroup analysis also demonstrated statistical significance 11.1% vs 1.8% (P = 0.0324) in the ≤30% vs >30% subgroups. No-reflow phenomenon was more prevalent in patients with reduced LVEF (LVEF ≤30%: 11.1%, LVEF 31-50%: 2.4%, LVEF >50%: 0%; P = 0.0190). Otherwise, no significant differences in in-hospital MACE, or mortality were observed. CONCLUSION RA can be effectively utilized in patients with severely reduced LVEF; however, these patients are at increased risk of prolonged procedural hypotension requiring bailout hemodynamic support. If indicated, prompt implementation of hemodynamic support mitigated any impact of procedural hypotension on in-hospital MACE and mortality.
Cardiovascular Revascularization Medicine | 2017
Hoyle Whiteside; Supawat Ratanapo; Albert Sey; Abdullah Omar; Deepak Kapoor
INTRODUCTION The efficacy of heparin based flush solutions in rotational atherectomy (RA) has not been validated. Recently, a single center study demonstrated the feasibility of an alternative flush solution with 10,000U of unfractionated heparin (UFH) in 1L of normal saline. We aimed to evaluate the safety and efficacy of an alternative flush solution intermittently utilized at our institution. METHODS We retrospectively identified 150 patients undergoing RA over a three year period. One hundred cases utilized an alternative flush solution containing 10,000U UFH, 400mcg nitroglycerin, and 10mg verapamil in 1L normal saline and fifty cases utilized RotaGlide Lubricant (Boston Scientific) in addition to heparin and vasodilators in the same dose. The primary end point was to compare rates of procedural success. Secondary endpoints were to report procedural characteristics including the incidence of major adverse cardiac events (MACE) and minor periprocedural complications. RESULTS Procedural success was achieved in 98% (98/100) of cases utilizing the alternative Rota-Flush solution compared to 100% (50/50) in the Rota-Glide group (P=0.553). A total of 292 lesions (200 Rota-Flush vs 92 Rota-Glide) were targeted for intervention. MACE occurred in 13 (13%) and 4 (8%) cases in the Rota-Flush and Rota-Glide groups, respectively (P=0.425). CONCLUSION Rotational atherectomy performed with the previously defined Rota-Flush or Rota-Glide solutions resulted in similar rates of procedural success. There were no significant disparities in incidence of MACE and minor periprocedural complications between the two groups. Heparin based rota-flush solutions can be effective alternatives to traditional solutions containing RotaGlide Lubricant.
Journal of the American College of Cardiology | 2018
Hoyle Whiteside; Kristen Brown; Arun Nagabandi; Supawat Ratanapo; Gyanendra Sharma
Jacc-cardiovascular Interventions | 2018
Hoyle Whiteside; Supawat Ratanapo; Tarun Sharma; Arun Nagabandi; Deepak Kapoor
Jacc-cardiovascular Interventions | 2018
Hoyle Whiteside; Supawat Ratanapo; Arun Nagabandi; Deepak Kapoor
Vascular Disease Management | 2017
Arun Nagabandi; Supawat Ratanapo; Loren Garrison Morgan; Deepak Kapoor
Journal of the American College of Cardiology | 2017
Abdullah Omar; Supawat Ratanapo; Deepak Kapoor; Sean P. Javaheri
Jacc-cardiovascular Interventions | 2017
Hoyle Whiteside; Supawat Ratanapo; Albert Sey; Abdullah Omar; Arun Nagabandi; Deepak Kapoor
Anesthesia & Analgesia | 2017
Shvetank Agarwal; Gyanendra Sharma; Supawat Ratanapo; Nadine Odo; Sean P. Javaheri